FDA recall D-388-2014

GlaxoSmithKline, LLC. · Class II · drug

Product

Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.

Reason for recall

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2013-11-06
Report date
2014-01-01
Termination date
2014-08-20
Voluntary/Mandated
Voluntary: Firm initiated
Location
Zebulon, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-388-2014